RxDoctor Payments Data

Robert Greer, DO

Family Medicine · Lake Park, FLNPI 1053319533

Payments from drug & device makers

$3,951in general payments, 2019–2025

Across 137 payments — averaging $28.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$434
  • Pfizer$262
  • Lilly USA, LLC$234
  • GSK$205
  • Stryker$169
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,944100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,951 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$56,339
Medicare patients
110
Services billed
608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$23,521
JardianceEmpagliflozin14$15,485
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,913
DiovanValsartan12$7,198
Rosuvastatin Calcium57$771
Levothyroxine Sodium47$394
Simvastatin45$364
Ezetimibe23$362
Losartan Potassium43$360
Metformin Hcl53$346
Tamsulosin Hcl26$329
Metoprolol Succinate15$296
Amlodipine Besylate68$289
Atorvastatin Calcium17$270
Alprazolam28$259

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$262$23,52114 claims
Boehringer IngelheimJardiance$166$15,48514 claims
GSKTrelegy Ellipta$205$10,91317 claims
NovartisDiovan$106$7,19812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Lake Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →